Jack Gleeson

Associate Professor in Medical Oncology

Cork University Hospital

Ireland

Research Interests

Explore related searches

Professors in Ireland Professors in Immunology Immunology professors in Ireland

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Jack Gleeson is an Associate Professor in Medical Oncology at Cork University Hospital, Ireland. His research primarily focuses on the management and treatment of various cancers, including germ cell tumors, testicular cancer, and glioblastoma multiforme. He has published extensively on topics such as chemotherapy protocols, supportive care interventions, and molecular characterization of renal cell carcinoma. Through his work, Dr. Gleeson aims to improve outcomes for patients with advanced cancers.

Articles (10)

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Collaborators (4)

Juan W. Valle

The University of Manchester

UNITED KINGDOM

View details

Mairéad Mcnamara

The University of Manchester

UNITED KINGDOM

View details

Maria O'Malley

IRELAND

View details

Mike Murphy

Lecturer

University College Cork

IRELAND

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Jack Gleeson

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Paclitaxel, Ifosfamide, and Cisplatin as Initial Salvage Chemotherapy for Germ Cell Tumors: Long-Term Follow-Up and Outcomes for Favorable- and Unfavorable-Risk Disease

Paclitaxel, Ifosfamide, and Cisplatin as Initial Salvage Chemotherapy for Germ Cell Tumors: Long-Term Follow-Up and Outcomes for Favorable- and Unfavorable-Risk Disease.

Testicular cancer in 2023: Current status and recent progress

Supportive care interventions for men with urological cancers: a scoping review

Targeting PD-1/PD-L1 in biliary tract cancer; role and available data

Prognosis Discussion and Referral to Community Palliative Care Services in Patients with Advanced Pancreatic Cancer Treated in a Tertiary Cancer Centre

Management of newly diagnosed glioblastoma multiforme: current state of the art and emerging therapeutic approaches

Comprehensive Molecular Characterization and Response to Therapy in Fumarate Hydratase–Deficient Renal Cell Carcinoma

Comprehensive Molecular Characterization and Response to Therapy in Fumarate Hydratase-Deficient Renal Cell Carcinoma.

Similar overall survival with reduced vs. standard dose bevacizumab monotherapy in progressive glioblastoma

Collaborators (4)

Juan W. Valle

Mairéad Mcnamara

Maria O'Malley

Mike Murphy

Make your next move.